Skip to main content
Caplight Logo









GlycoSpot

GlycoSpot

Private
DenmarkFrontier & Industrial Techhttps://www.glycospot.dk/

Last Round

Strategic

Mar 27, 2025

Total Funding Raised

$270,000

Company Overview

GlycoSpot is a biotechnology company that develops application-specific enzyme test methods that are fast to implement and easy to use for companies in the food and beverage industry.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Biotech Equipment, Quality Management

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

enzyme activity testingenzyme assaysat-line testingrapid enzyme analysisenzyme test kitsportable labprocess analytical technologyPATpoint-of-need testingfood quality controlbiotech equipmenthigh-throughput screeningcustom assay developmentclean-in-place validationportable spectrophotometer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlycoSpot Comparables

Compare GlycoSpot with similar companies based on industry and business-model similarity.

GlycoSpot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CDR s.r.l.
80%
Neogen Corporation
76%
SIRION Biotech
70%

GlycoSpot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 27, 2025

Key People

Founding team and executive leadership

Michael Stanley Pedersen

Chief Executive Officer

Executive Team

GlycoSpot Investors

Notable investors and investment history

GlycoSpot investors
InvestorRounds
Innovation Fund DenmarkGrant
Danish Tech ChallengeAccelerator
CapnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Grew 27% QoQ, from 15 to 19 employees.

  • Feb 18, 2026

    Grew 73% QoQ, from 11 to 19 employees.

GlycoSpot Filings

Explore SEC and related filing metadata, where available.

GlycoSpot filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GlycoSpot's valuation, stock price, and market status.

Is GlycoSpot a public or private company?

GlycoSpot is a private company.

What is the current stock price of GlycoSpot?

GlycoSpot is a private company with no public stock price. No recent secondary market data is available.

How much is GlycoSpot worth (valuation)?

Valuation information for GlycoSpot is not publicly available.

Can I buy GlycoSpot stock?

GlycoSpot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GlycoSpot's last funding round?

Funding round information for GlycoSpot is not publicly available.

Who are the main investors in GlycoSpot?

Investor information for GlycoSpot is not publicly disclosed.

Will GlycoSpot IPO soon?

No public IPO plans have been announced for GlycoSpot.

How can I track GlycoSpot secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlycoSpot's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDenmark
Employee Range15
Year Founded2014
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?